ATOMO DIAGNOSTICS LIMITED — Capital/Financing Update 2023

Aug 7, 2023

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

ATOMO DIAGNOSTICS LIMITED

Announcement Type

New announcement

Date of this announcement

Tuesday August 08, 2023

The +securities to be quoted are:

==> picture [8 x 8] intentionally omitted <==

Other

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
AT1	ORDINARY FULLY PAID	33,333,387	08/08/2023

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 6

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

ATOMO DIAGNOSTICS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ABN

Registration number 37142925684

1.3 ASX issuer code

AT1

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

8/8/2023

Application for quotation of +securities

2 / 6

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

==> picture [8 x 8] intentionally omitted <==

Other

2.2 The +securities to be quoted are:

==> picture [8 x 9] intentionally omitted <==

Additional +securities in a class that is already quoted on ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure document or +PDS?

==> picture [8 x 8] intentionally omitted <==

No

2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

The shares were the subject of the Appendix 3B covering the proposed issue of shares under the SPP lodged on ASX on 13 July 2023.

2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

Application for quotation of +securities

3 / 6

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Additional +securities to be quoted in an existing class ASX +security code and description AT1 : ORDINARY FULLY PAID Issue date 8/8/2023 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 33,333,387 Are the +securities being issued for a cash consideration? Yes In what currency is the cash consideration being paid? What is the issue price per +security? AUD - Australian Dollar AUD 0.03000000 Any other information the entity wishes to provide about the +securities to be quoted The purpose(s) for which the entity is issuing the securities Other Please provide additional details To fund hCG Pregnancy Test sales & marketing (ANZ/US); Iron Deficiency Test registration & commercial activity (ANZ/UK and Europe); POC Technology (OEM) business development; Product development (app, digital, Vitamin D); and working capital requirements

Application for quotation of +securities

4 / 6

Application for quotation of +securities

Part 4 - Issued capital following quotation

==> picture [21 x 22] intentionally omitted <==

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

	ASX +security code and descriptionTotal number of+securities on issueAT1 : ORDINARY FULLY PAID639,202,310	ASX +security code and descriptionTotal number of+securities on issueAT1 : ORDINARY FULLY PAID639,202,310
	2 Unuoted +securities (total number of each +class of +securities issued but not uoted on ASX)
	. q q
	Total number of
	SX +security code and description+securities on issue
	AT1AJ : OPTION EXPIRING 14-APR-2024 EX $0.251,079,999
	AT1AM : OPTION EXPIRING 14-APR-2025 EX $0.251,199,999
	AT1AI : OPTION EXPIRING VARIOUS DATES EX 25C1,600,000
	AT1AL : OPTION EXPIRING 30-APR-2024 EX $0.602,000,000
	AT1AK : OPTION EXPIRING 30-APR-2024 EX $0.402,000,000
	AT1AN : OPTION EXPIRING 01-JUL-2027 EX $00356100000
.,,	.,,

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

Application for quotation of +securities

5 / 6

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? Yes

5.1a Select the number of the applicable exception in Listing Rule 7.2

5

Application for quotation of +securities

6 / 6